Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Adjuvant hepatic arterial infusion chemotherapy is beneficial for selective patients with Hepatocellular carcinoma undergoing surgical treatment
Jui‐Hu Hsiao, Cheng‐Chung Tsai, Tsung‐Jung Liang, et al.
International Journal of Surgery (2017) Vol. 45, pp. 35-41
Open Access | Times Cited: 37

Showing 1-25 of 37 citing articles:

Overexpression of YTHDF1 is associated with poor prognosis in patients with hepatocellular carcinoma
Xianguang Zhao, Chen Yang, Qiqi Mao, et al.
Cancer Biomarkers (2018) Vol. 21, Iss. 4, pp. 859-868
Closed Access | Times Cited: 211
Adjuvant treatment strategy after curative resection for hepatocellular carcinoma
Wei Zhang, Bixiang Zhang, Xiaoping Chen
Frontiers of Medicine (2021) Vol. 15, Iss. 2, pp. 155-169
Closed Access | Times Cited: 69
Adjuvant stereotactic body radiotherapy after marginal resection for hepatocellular carcinoma with microvascular invasion: A randomised controlled trial
Changying Shi, Yong Li, Li Geng, et al.
European Journal of Cancer (2022) Vol. 166, pp. 176-184
Closed Access | Times Cited: 38
Management of hepatocellular carcinoma recurrence after liver surgery and thermal ablations: state of the art and future perspectives
Astrid Herrero, Cyprien Toubert, José Ursic Bedoya, et al.
HepatoBiliary Surgery and Nutrition (2024) Vol. 13, Iss. 1, pp. 71-88
Open Access | Times Cited: 8
Current status and prospect of treatments for recurrent hepatocellular carcinoma
Yuqing Yang, Zhen-Yu Wen, Xiaoyan Liu, et al.
World Journal of Hepatology (2023) Vol. 15, Iss. 2, pp. 129-150
Open Access | Times Cited: 14
Multiple m6A RNA methylation modulators promote the malignant progression of hepatocellular carcinoma and affect its clinical prognosis
Nanfang Qu, Sanyu Qin, Xuemei Zhang, et al.
BMC Cancer (2020) Vol. 20, Iss. 1
Open Access | Times Cited: 39
Advances in postoperative adjuvant therapy for primary liver cancer
Zhiming Zeng, Ning Mo, Jie Zeng, et al.
World Journal of Gastrointestinal Oncology (2022) Vol. 14, Iss. 9, pp. 1604-1621
Open Access | Times Cited: 21
Postoperative adjuvant therapy for hepatocellular carcinoma with microvascular invasion
Li Jiang, Fan Yang, Jian Li, et al.
World Journal of Gastrointestinal Surgery (2023) Vol. 15, Iss. 1, pp. 19-31
Open Access | Times Cited: 11
Totally Percutaneous Hepatic Arterial Infusion Chemotherapy
Daniel P. Nussbaum, Chandrasekhar Padmanabhan
(2025), pp. 323-335
Closed Access
Does postoperative adjuvant transarterial chemoembolization benefit for all patients with hepatocellular carcinoma combined with microvascular invasion: a meta-analysis
Lei Wang, Qiao Ke, Nanping Lin, et al.
Scandinavian Journal of Gastroenterology (2019) Vol. 54, Iss. 5, pp. 528-537
Closed Access | Times Cited: 29
Systematic Analyses of the Role of the Reader Protein of N6-Methyladenosine RNA Methylation, YTH Domain Family 2, in Liver Hepatocellular Carcinoma
Xiangyang Shao, Jin‐Tang Dong, Han Zhang, et al.
Frontiers in Molecular Biosciences (2020) Vol. 7
Open Access | Times Cited: 24
The Role of Hepatic Arterial Infusion Chemotherapy in the Treatment of Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis
Shengzhou Li, Jiaxuan Xu, Hongya Zhang, et al.
Chemotherapy (2021) Vol. 66, Iss. 4, pp. 124-133
Open Access | Times Cited: 22
Phyto-sesquiterpene lactone deoxyelephantopin and cisplatin synergistically suppress lung metastasis of B16 melanoma in mice with reduced nephrotoxicity
Wen‐Wan Chao, Ya‐Wen Cheng, Yet‐Ran Chen, et al.
Phytomedicine (2018) Vol. 56, pp. 194-206
Closed Access | Times Cited: 26
Challenges in Chemotherapy Delivery: Comparison of Standard Chemotherapy Delivery to Locoregional Vascular Mass Fluid Transfer
Rodney J. Lane, Nyan Y. Khin, Nick Pavlakis, et al.
Future Oncology (2018) Vol. 14, Iss. 7, pp. 647-663
Open Access | Times Cited: 24
Adjuvant therapy following curative treatments for hepatocellular carcinoma: current dilemmas and prospects
Bin Guo, Qian Chen, Zhicheng Liu, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 8
Human nuclear receptors (NRs) genes have prognostic significance in hepatocellular carcinoma patients
Guangtao Sun, Sun Kejian, Chao Shen
World Journal of Surgical Oncology (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 16
Does adjuvant hepatic artery infusion chemotherapy improve patient outcomes for hepatocellular carcinoma following liver resection? A meta-analysis
Lingbo Hu, Yu Zheng, Jiangyin Lin, et al.
World Journal of Surgical Oncology (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 7
Comparison of different adjuvant therapy regimen efficacies in patients with high risk of recurrence after radical resection of hepatocellular carcinoma
Feng Xu, Guoying Feng, Jie Tao, et al.
Journal of Cancer Research and Clinical Oncology (2023) Vol. 149, Iss. 12, pp. 10505-10518
Closed Access | Times Cited: 7
Immunotherapy as a Complement to Surgical Management of Hepatocellular Carcinoma
Susan J. Kim, Kaelyn C. Cummins, Allan Tsung
Cancers (2024) Vol. 16, Iss. 10, pp. 1852-1852
Open Access | Times Cited: 2
Nomograms established for predicting microvascular invasion and early recurrence in patients with small hepatocellular carcinoma
X. L. Wang, Xin-Qun Chai, Ji Zhang, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 2
<p>Not All Hepatocellular Carcinoma Patients with Microvascular Invasion After R0 Resection Could Be Benefited from Prophylactic Transarterial Chemoembolization: A Propensity Score Matching Study</p>
Lei Wang, Qiao Ke, Kongying Lin, et al.
Cancer Management and Research (2020) Vol. Volume 12, pp. 3815-3825
Open Access | Times Cited: 15
Meta-Analysis of Postoperative Adjuvant Hepatic Artery Infusion Chemotherapy Versus Surgical Resection Alone for Hepatocellular Carcinoma
Qiao Ke, Lei Wang, Weimin Wu, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 14
Establishment of Prognostic Signatures of N6-Methyladenosine-Related lncRNAs and Their Potential Functions in Hepatocellular Carcinoma Patients
Xianbin Wu, Zhejun Deng, Xiaomin Liao, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 10
Organic cation transporter 3 mediates cisplatin and copper cross-resistance in hepatoma cells
Sarah Guttmann, Gursimran Chandhok, Sara Reinartz Groba, et al.
Oncotarget (2017) Vol. 9, Iss. 1, pp. 743-754
Open Access | Times Cited: 16
Adjuvant transarterial chemoembolization for patients with hepatocellular carcinoma after radical hepatectomy: a real world study
Lei Wang, Qiao Ke, Manjun Deng, et al.
Scandinavian Journal of Gastroenterology (2019) Vol. 54, Iss. 11, pp. 1403-1411
Closed Access | Times Cited: 14
Page 1 - Next Page

Scroll to top